Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Over but not gone: lingering epigenetic effects of COVID-19

Trends in Immunology(2023)10.1016/j.it.2023.08.012Source: DataRank Database

Over but not gone: lingering epigenetic effects of COVID-19 is a research paper published in Trends in Immunology (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Ruoqiong Cao ORCID,Katherine Y. King ORCID,Brandon T. Tran ORCID

Live enrichment

PubMed:37704548 PMC:PMC10543559 OpenAlex:https://openalex.org/W4386607453

National Heart Lung and Blood Institute

Grant: F31 HL164287

National Heart Lung and Blood Institute

Grant: R35 HL155672

National Cancer Institute

Grant: P01 CA265748

National Institutes of Health

Grant: AI141716

NHLBI NIH HHS

Grant: T32 HL092332

NIAID NIH HHS

Grant: R01 AI141716

FWCI

0.00

Citation Percentile

0.1%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10543559/pdf/nihms-1928888.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1471490623001801?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471490623001801?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10543559

Fields of Study

Immune responses and vaccinationsLong-Term Effects of COVID-19Immune cells in cancerAdultHumansCOVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeEpigenesis, Genetic

MeSH Terms

COVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeAdultHumansEpigenesis, Genetic

Keywords

EpigeneticsCoronavirus disease 2019 (COVID-19)ImmunologyBiology2019-20 coronavirus outbreakImmune systemDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicProgenitor cellCoronavirusMedicineStem cellVirologyGeneticsInfectious disease (medical specialty)GeneInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being